UK Medtech Ltd - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 08052915 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2019

FOR

UK MEDTECH LTD

Page

Balance Sheet

1

FIXED ASSETS

11,040

9,764

CURRENT ASSETS

71,022

49,638

CREDITORS

Amounts falling due within one year

(35,667

)

(31,215

)

NET CURRENT ASSETS

35,355

18,423

TOTAL ASSETS LESS CURRENT LIABILITIES

46,395

28,187

CAPITAL AND RESERVES

46,395

28,187

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

UK Medtech Ltd is a private company, limited by shares , registered in England and Wales. The company's

registered number and registered office address are as below:

Registered number:

08052915

Registered office:

17 Hen Street

Bradninch

Exeter

Devon

EX5 4NR

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2018 - 1 ) .

3.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

Included within Creditors is an amount owed by the company to the director of £9,413 (2018: £14,677) The loan

is interest free and there are no terms of repayment.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2019 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director on 21 February 2020 and were signed by:

G C J Cooper - Director